Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of CANC's 48 holdings also in XDNA
nan%
% of XDNA's 3 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
 |
REVOLUTION MEDICINES, INC. | 5.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% |
|
ELI LILLY & CO | 5.1% |
|
BRIDGEBIO PHARMA, INC. | 4.9% |
 |
ASTRAZENECA PLC | 4.5% |
|
NOVARTIS AG | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
|
EXELIXIS INC | 4.0% |
|
SUMMIT THERAPEUTICS INC | 4.0% |
|
NUVALENT, INC. CLASS A | 3.9% |
CANC Underweight Relative to XDNA
|
ARCUS BIOSCIENCES, INC. | 0.2% |
|
CELCUITY INC. | 0.3% |
|
AUTOLUS THERAPEUTICS PLC SPONSORED A | 0.3% |
|
ORIC PHARMACEUTICALS INC | 0.4% |
|
RELAY THERAPEUTICS, INC. | 0.4% |
|
SYNDAX PHARMACEUTICALS INC | 0.4% |
|
ARVINAS, INC. | 0.4% |
|
ILLUMINA INC | 0.5% |
|
REPLIMUNE GROUP, INC. | 0.5% |
|
INCYTE CORP | 0.5% |